Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Pro Medicus Limited ( (AU:PME) ).
Pro Medicus Limited has announced a change in the director’s interest, with Anthony Glenning, a director of the company, acquiring 50 additional ordinary shares through an on-market purchase. This change reflects a minor adjustment in the director’s holdings, indicating continued confidence in the company’s performance and potential growth, which may reassure stakeholders about the company’s stability and future prospects.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare technology industry, providing advanced imaging software and services to medical professionals and institutions. The company focuses on delivering innovative solutions that enhance diagnostic capabilities and improve patient care.
YTD Price Performance: 2.72%
Average Trading Volume: 306
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $16.78B
For a thorough assessment of PME stock, go to TipRanks’ Stock Analysis page.